Watson Pharmaceuticals, Inc. Company Profile

18:12 EDT 27th April 2015 | BioPortfolio

Itero Biopharmaceuticals, Inc. is a San Mateo, California-based specialty biopharmaceutical developer focused on clinically and commercially differentiated protein therapeutics. Itero leverages strategic collaborations to provide capital efficient process and manufacturing development as well as global clinical development and commercialization. The company's management team consists of accomplished executives with extensive development, manufacturing and commercialization experience relating to therapeutic proteins, including monoclonal antibodies. For additional information on Itero Biopharmaceuticals, please visit the company's Web site at http://www.iterobiopharm.com.


News Articles [91 Associated News Articles listed on BioPortfolio]

The Trouble With Jim (Watson, That Is)

Colleagues, writers, readers, hear me for my cause…I come not to bury Watson, but to historicize him. James Watson has not been in the news much in recent years. In […]

Want a Nobel Prize? You can buy one… Watson’s, in fact.

Well, this is tragic. James Watson – yes, the Watson & Crick Watson – is auctioning off his Nobel Prize because he’s short of cash. Ever since a public outing of some IQ-rela...

Massive IBM deal gives Watson purpose and puts it in pole position to transform healthcare

For years Watson wandered in the wilderness of healthcare while IBM sought any partner it could to feed a beast that simply wanted more medical data. Watson grew up all...

IBM Sees Opportunities in Care Management with Watson Health

Computerworld | After years of experiments using its Watson cognitive computing technology in medical settings, IBM announced this week the creation of a Watson Health business unit that will provide ...

Watson-Marlow Acquires ASEPCO Corporation

Watson-Marlow Fluid Technology Group strengthens its biopharmaceutical offering through the acquisition of

How IBM transformed Watson into healthcare resource

There’s an interesting article in USA Today this week about how IBM approach to its Watson division led to it playing a critical role in making big data less unwieldy,...

Watson Health is IBM’s ‘moonshot,’ here’s the best health story of 2014 (Morning Read)

CEO of IBM Ginni Rometty feels extremely optimistic about Watson Health and the Baird 2015 Growth Stock Conference will feature PerkinElmir.

Watson-Marlow buys aseptic processing equipment firm

Watson-Marlow has shelled out £7m ($10m) to add high purity equipment company Asepco to bolster its bioprocessing offerings.

Drugs and Medications [60 Associated Drugs and Medications listed on BioPortfolio]

Cormax [Watson Pharma, Inc. ]

70010599meclizine hcitablets usprx only [Watson Laboratories, Inc.]

70010599Meclizine HCITablets USPRx only

Chlorzoxazone [Watson Laboratories, Inc.]

CHLORZOXAZONE TABLETS, USP 500 mg Revised:  November 2010 Rx only 195609

Chlorzoxazone [Watson Laboratories, Inc.]

CHLORZOXAZONE TABLETS, USP 500 mg Revised:  November 2010 Rx only 195609

Hydroxocobalamin [Watson Laboratories, Inc.]

HYDROXOCOBALAMIN INJECTION USP Rx only

PubMed Articles [37 Associated PubMed Articles listed on BioPortfolio]

Watson Will See You Now: A Supercomputer to Help Clinicians Make Informed Treatment Decisions.

IBM has collaborated with several cancer care providers to develop and train the IBM supercomputer Watson to help clinicians make informed treatment decisions. When a patient is seen in clinic, the on...

Isostericity and Tautomerism of Base Pairs in Nucleic Acids.

The natural bases of nucleic acids form a great variety of base pairs with at least two hydrogen bonds between them. They are classified in twelve main families, with the Watson-Crick family being one...

Structure of the DNA Duplex d(ATTAAT)2 with Hoogsteen Hydrogen Bonds.

The traditional Watson-Crick base pairs in DNA may occasionally adopt a Hoogsteen conformation, with a different organization of hydrogen bonds. Previous crystal structures have shown that the Hoogste...

Effect of ancillary ligands on the interaction of ruthenium(II) complexes with the triplex RNA poly(U)·poly(A)*poly(U).

Two new Ru(II) complexes with 1,8-naphthalimide group, [Ru(phen)2(pnip)](2+) (Ru1; phen=1,10-phenanthroline, pnip=2-[N-(p-phenyl)-1,8-napthalimide]imidazo[4',5'-f][1,10]phenanthroline) and [Ru(bpy)2(p...

Caring Science, Mindful Practice: Implementing Watson's Human Caring Theory, by K. Sitzman and J. Watson. (New York: Springer, 2014).

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Comparative Bioavailability Study of Baclofen 20 mg Tablets in Healthy Male Volunteers / Fasting State

The objective of this study was to investigate the bioequivalence of Genpharm's baclofen tablets following a single, oral 20 mg (1 x 20 mg) dose compared to the Baclofen USP (Watson Labora...

A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatmen

A multi-center, double-blind, randomized, placebo controlled, parallel-group study, comparing Clindamycin phosphate vaginal cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™,...

Comparison of Two Minimally Invasive Surgical Techniques for Hip Replacement

Comparison of the clinical effectiveness and cost-effectiveness of the MIS anterolateral approach (MIS Watson Jones, G3) versus anterolateral mini or posterolateral mini approaches in prim...

Evaluation of Four Surgical Techniques in Primary Total Hip Arthroplasty

Current "Minimally Invasive THR" includes: (1) Minimally Invasive Two-Incision THR (MIS-2), (2) Minimally Invasive Modified Watson-Jones THR (MIS-WJ). In contrast, "mini-incision" utilizes...

Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea

A Randomized, Double-Blind, Multiple-Site, Placebo-Controlled, Parallel-Design Study to Evaluate the Safety and Therapeutic Equivalence of Brimonidine Topical Gel, 0.33% (Watson Laboratori...

Companies [19 Associated Companies listed on BioPortfolio]

Watson Inc.

Watson is one of the highest quality suppliers of products and services geared towards enhancing human health and nutrition around the world. We are a leader in developing quality...

Watson Pharmaceuticals

Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets and distributes brand and generic pharmaceutical p...

Watson Clinic LLP

Watson Clinic was established in 1941 in Lakeland, Florida. At that time, a medical group comprised of two surgeons, two internist, and a urologist, whose professional unity had already been establis...

Towers Watson

Towers Watson (NYSE, NASDAQ: TW) is a leading global professional services company that helps organizations improve performance through effective people, risk and financial manage...

Watson Wyatt

Watson Wyatt (NYSE, Nasdaq: WW) is the trusted business partner to the world's leading organizations on people and financial issues. The firm's global services include: managing the cost and effective...

More Information about "Watson Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Watson Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Watson Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Watson Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Watson Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Watson Pharmaceuticals, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record